Antiapoptotic inhibitors of the BCL-2 family synergize with tetrathiomolybdate to induce apoptosis in melanoma cells resistant to BRAF and MEK1/2 inhibitors [62]. The gene discussed is MAP2K1; the disease is melanoma.